| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
648 |
604 |
$36K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
67 |
60 |
$19K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
157 |
146 |
$5K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
66 |
65 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
130 |
123 |
$3K |
| 80053 |
Comprehensive metabolic panel |
113 |
90 |
$501.56 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
117 |
98 |
$359.39 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
33 |
32 |
$330.16 |
| 87420 |
|
18 |
17 |
$231.47 |
| 71045 |
Radiologic examination, chest; single view |
13 |
12 |
$230.90 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
13 |
12 |
$68.49 |
| 81001 |
|
29 |
26 |
$61.67 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
20 |
13 |
$27.40 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14 |
13 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14 |
12 |
$0.00 |